MedTrace Logo

Mental Attention-neuromuscular Training for Children With Developmental Coordination Disorder

NCT02397161 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 172

Last updated 2015-12-15

No results posted yet for this study

Summary

Objective: To compare the effectiveness of EEG biofeedback mental attention-neuromuscular training (AT-NMT), neuromuscular training (NMT) alone, EEG biofeedback mental attention training (AT) alone, and no intervention for improving reactive balance performance among children with developmental coordination disorder (DCD).

Design: A single-blinded, randomized controlled clinical trial. Sample: 172 children with DCD. Interventions: AT-NMT, NMT, AT, or no intervention for 12 weeks. Major outcomes: Outcomes will be evaluated at baseline, post-intervention, and 3-month follow-up. A motor control test (MCT) will give a composite latency score, prefrontal cortex EEG recordings during MCT will measure the mental attention level, and surface electromyography recordings during MCT will indicate the lower limb muscle onset latency.

Conditions

  • Developmental Coordination Disorder

Interventions

OTHER

EEG biofeedback mental attention-neuromuscular training

Mental attention training using EEG biofeedback and neuromuscular training using physio-therapeutic exercises

OTHER

Neuromuscular training

Neuromuscular training using physio-therapeutic exercises

OTHER

EEG biofeedback mental attention training

Mental attention training using EEG biofeedback

Sponsors & Collaborators

  • The University of Hong Kong

    lead OTHER

Principal Investigators

  • Shirley SM Fong, PT, PhD · The University of Hong Kong

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
6 Years
Max Age
9 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-07-31
Primary Completion
2017-07-31
Completion
2017-07-31

Countries

  • Hong Kong

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02397161 on ClinicalTrials.gov